Amrutanjan Health Care enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,425	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
14.3	14.3	10.2	3.7	10.0
1,411	—	—	—	—
−14.3	−14.3	−10.2	−3.7	−10.0
₹488.04	—	—	—	—

370	370	327	288	291

2.76×	—	—	—	—
19.20×	—	—	—	—
21.13×	—	—	—	—
511	503	452	421	380
73.5	75.7	58.2	51.2	44.4
66.8	69.4	51.7	45.2	39.2
—	36.0	50.9	27.9	19.2
−19.0	−19.0	15.3	21.2	10.3
—	−19.1	15.3	21.1	10.3
—	55.0	35.6	6.7	8.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

AMRUTANJAN₹493.00

Amrutanjan Health Care Limited

· Pharma & Health

₹ CrorePeersJAGSNPHARM NGLFINE SIGACHI LINCOLN SYNCOMF THEMISMED HESTERBIOMcap ₹1,425 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,425.3
- Cash, Equiv & ST Investments	10.0	3.7	10.2	14.3	14.3
Enterprise Value	—	—	—	—	1,411.0
Net Debt (memo)	-10.0	-3.7	-10.2	-14.3	-14.3
EV per Share	—	—	—	—	488.04

Total Capital	290.8	288.5	326.6	370.2	370.2

EV/Sales	—	—	—	—	2.76
EV/EBITDA	—	—	—	—	19.20
EV/EBIT	—	—	—	—	21.13
Reference Items — Trailing FY Values
Sales	379.6	421.2	451.8	502.6	511.5
EBITDA	44.4	51.2	58.2	75.7	73.5
EBIT	39.2	45.2	51.7	69.4	66.8
Operating Cash Flow	19.2	27.9	50.9	36.0	—
Free Cash Flow	10.3	21.2	15.3	-19.0	-19.0
FCFF (free cash flow to the firm)	10.3	21.1	15.3	-19.1	—
Capital Expenditure	8.9	6.7	35.6	55.0	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.